CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale CEO sold 3,928 shares at $23.80 ($93,486)
- 4 Open-market sale EVP, COO, Head of Commercial sold 538 shares at $23.05 ($12,401)
- 4 Open-market sale EVP & General Counsel sold 574 shares at $23.05 ($13,231)
- 4 Open-market sale President sold 1,937 shares at $23.05 ($44,648)
- 4 Open-market sale CEO sold 3,718 shares at $23.05 ($85,700)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President sold 2,803 shares at $19.01 ($53,285)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President sold 1,338 shares at $17.41 ($23,295)
- 4 Open-market sale CEO sold 2,963 shares at $17.41 ($51,586)
- 4 Option exercise Director acquired 1,918 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 25,564 shares (grant or award)
- 4 Open-market sale EVP and CFO sold 1,032 shares at $20.33 ($20,981)
Page 10 of 35 · 686 filings